Phase IIIb Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Methadone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms EQUIMETH2
- 15 Feb 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01793480).
- 15 Feb 2013 Planned end date changed from 2 Nov 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 13 Feb 2013 New trial record